Cite
MLA Citation
Pedro A de Alarcon et al.. “Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.” Lancet, vol. 2, 2018, pp. 25–34. http://access.bl.uk/ark:/81055/vdc_100055342150.0x00000d